Predicting and preventing acute kidney injury after cardiac surgery

Current Opinion in Nephrology and Hypertension

Volumn 17, Issue 6, 2008, Pages 624-628

  Harel, Ziv ^a   Chan, Christopher T ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Acute kidney injury; Cardiac surgery; Prevention; Renal risk models

Indexed keywords

ACETYLCYSTEINE; BRAIN NATRIURETIC PEPTIDE; FENOLDOPAM MESILATE; FUROSEMIDE; NESIRITIDE; PLACEBO;

CLINICAL ASSESSMENT; CONTINUOUS INFUSION; DRUG MEGADOSE; HEART SURGERY; HUMAN; KIDNEY BLOOD FLOW; KIDNEY INJURY; LOW DRUG DOSE; NATRIURESIS; NONHUMAN; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURGICAL RISK;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR AGENTS; HUMANS; KIDNEY DISEASES; NATRIURETIC AGENTS; PREDICTIVE VALUE OF TESTS; RENAL CIRCULATION; RISK ASSESSMENT; RISK FACTORS;

EID: 56249146722     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32830f4590     Document Type: Review

References (48)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115:e69-e171.
2. Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 2005; 96:196-201.
3. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicentre Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128:194-203.
4. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997; 95:878-884.
5. Frost L, Pedersen RS, Lund O, et al. Prognosis and risk factors in acute, dialysis-requiring renal failure after open-heart surgery. Scand J Thorac Cardiovasc Surg 1991; 25:161-166.
6. Andersen LG, Ekroth R, Bratteby LE, et al. Acute renal failure after coronary surgery: a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg 1993; 41:237-241.
7. Zanardo G, Mictelon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate and main risk factors. J Thorac Cardiovasc Surg 1994; 107:1489-1495.
8. Fortescue EB, Bates DW, Chertow GM. Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms. Kidney Int 2000; 57:2594-2602.
9. Eriksen BO, Hoff KR, Solberg S. Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm. Nephrol Dial Transplant 2003; 18:77-81.
10. Thakar CV, Arrigain S, Worley S, et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16:162-168.
11. Mehta RH, Grab JD, O'Brien SM, et al., for the Society of Thoracic Surgeons National Cardiac Surgery Database investigators. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 2006; 114:2208-2216.
12. Wijeysundera DN, Karkouti KM, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007; 297:1801-1809. This paper highlights a new, simple model for predicting the risk of AKI requiring RRT after cardiac surgery.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2006; 39 (Suppl 1):S1-S266.
14. Noyez L, Plesiewicz I, Verheugt FW. Estimated creatinine clearance instead of plasma creatinine level as prognostic test for postoperative renal function in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 2006; 29:461-465.
15. Wang F, Dupuis JY, Nathan H, Williams K. An analysis of the association between preoperative renal dysfunction and outcome in cardiac surgery: estimated creatinine clearance or plasma creatinine level as measures of renal function. Chest 2003; 124:1852-1862.
16. Brown JR, Cochran RP, Leavitt BJ et al., for the Northern New England Cardiovascular Disease Study Group. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation 2007; 116 (I Suppl):I139-I143.
17. Brown JR, Cochran RO, Dacey LJ, et al. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation 2006; 114 (I Suppl):I409-I413.
18. Palomba H, de Castro I, Neto AL, et al. Acute-kidney injury prediction following elective cardiac surgery: AKICS score. Kidney nt 2007; 72:624-631.
19. Ranucci M, Soro G, Barzaghi N, et al. Fenoldopam prophylaxis of post-operative acute renal failure in high-risk cardiac surgery patients [discussion 1337-1337]. Ann Thorac Surg 2004;78:1332-1337.
20. Kramer BK, Preuner J, Ebenburger A, et al. Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant 2002; 17:910-915.
21. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000; 11:97-104.
22. Moran SM, Myers BD. Pathophysiology of protracted acute renal failure in man. J Clin Invest 1985; 76:1440-1448.
23. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for a change? J Am Soc Nephrol 2003; 14:2178-2187.
24. Mehta RL. Indications for dialysis in the ICU: renal replacement vs. renal support. Blood Purif 2001; 16:227-232.
25. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212.
26. Bennett M, Dent CL, Ma Q, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3:665-673. This study demonstrates the utility of NGAL as a novel biomarker to detect AKI at an early stage after cardiac surgery.
27. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006; 1:19-32.
28. Rosner MH, Portilla D, Okusa MD. Cardiac surgery as a cause of acute kidney injury: pathogenesis and potential therapies. J Intensive Care Med 2008; 23:3-18. This is an update of Rosner and Okusa's 2006 review article [27].
29. Caimmi PP, Pagani L, Micalizzi E, et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003; 17:491-494.
30. Garwood S, Swamidoss CP, Davis EA, et al. A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth 2003; 17:17-21.
31. Cogliati AA, Velluntini R, Nardini A, et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized control clinical study. J Cardiothorac Vasc Anesth 2007; 21:847-850.
32. Landoni G, Biondi-Zoccai GGL, Tumlin JA, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 2007; 49:56-68.
33. Heyman SN, Brezis M, Greenfeld Z, Rosen S. Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 1989; 14:377-385.
34. Lombardi R, Ferreiro A, Servetto C. Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail 2003; 25:775-786.
35. Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 2000; 69:501-506.
36. Mahesh B, Yim B, Robson D, et al. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomized trial. Eur J Cardiothorac Surg 2008; 33:370-376.
37. Houben AJHM, van der Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol 2005; 19:411-419.
38. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339:321-328.
39. Beaver TM, Winterstein AG, Shuster JJ, et al. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 2006; 29:18-24.
40. Salzberg SP, Filsoufi F, Anyanwu A, et al. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005; 80:502-506.
41. Chen HH, Sundt TM, Cook DJ, et al. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery. A double-blind placebo-controlled pilot study. Circulation 2007; 116 (Suppll):I134-I138.
42. Mentzer RM Jr, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J Am Coll Cardiol 2007; 49:716-726.
43. Burns KEA, Chu MWA, Novick RJ, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk surgical patients undergoing CABG surgery. A randomized control trial. JAMA 2005; 294:342-350.
44. Haase M, Haase-Fielitz A, Bagshaw SM, et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007; 35:1324-1331.
45. Wijeysundera DN, Beattie WS, Rao V, et al. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with preexisting moderate renal insufficiency. Can J Anesth 2007; 54:872-881.
46. Sisillo E, Ceriani R, Bortone F, et al. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med 2008; 36:81-86.
47. DiMari J, Megyesi J, Udvarhelyi N, et al. N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272:F292-F298.
48. Conesa EL, Valero F, Nadal JC, et al. N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 2001; 281:R730-R737.